RxDoctor Payments Data

Arti Ori, MD

Pain Medicine · Boston, MANPI 1326160847

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (53.6%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Medtronic accounts for 80.6% of it on its own, with 27 other manufacturers making up the rest. 2025 is the largest year on record at $30,785, more than ten times the $584 reported in 2019. Among pain medicine clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$62,467in general payments, 2019–2025

Across 368 payments — averaging $169.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$50K
  • Abbott$7K
  • Boston Scientific$2K
  • SPR Therapeutics, Inc$521
  • Saluda Medical Americas, Inc.$475
  • Nevro Corp.$333
  • plus $2K from 22 others
$42,905in research payments, 2019–2025

Across 2 payments — averaging $21,453 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$43K

What the payments were for

  • Consulting fees$1,2002%
  • Speaking & faculty fees$33,50054%
  • Travel & lodging$13,96322%
  • Food & beverage$13,76522%
  • Education$390%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$62,467 in reported general payments places this provider in the 95th percentile of 137 pain medicine providers in Massachusetts.

See all pain medicine providers in Massachusetts

Medicare billing

Part B allowed, 2024
$118,553
Medicare patients
406
Services billed
1,119

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine16$2,196
Baclofen80$1,859
Pregabalin80$1,843
Gabapentin89$1,603
Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine29$1,469
Lidocaine24$1,436
Oxycodone Hcl63$1,114
Tizanidine Hcl59$796
Cyclobenzaprine Hcl23$369
Celecoxib13$351
Diclofenac Sodium11$238
Morphine Sulfate12$215
Hydromorphone Hcl12$140
Meloxicam27$134
Methadone Hcl12$99

Paid to pharmacies, not to this prescriber.

Other pain medicine in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →